investorscraft@gmail.com

Intrinsic Value of HTG Molecular Diagnostics, Inc. (HTGM)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-03-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-28.5NaN
Revenue, $6NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m27NaN
Operating income, $m-21NaN
EBITDA, $m-20NaN
Interest expense (income), $mNaN
Earnings before tax, $m-43NaN
Tax expense, $m-22NaN
Net income, $m-22NaN

BALANCE SHEET

Cash and short-term investments, $m12NaN
Total assets, $m18NaN
Adjusted assets (=assets-cash), $m6NaN
Average production assets, $m3NaN
Working capital, $m7NaN
Total debt, $m8NaN
Total liabilities, $m12NaN
Total equity, $m5NaN
Debt-to-equity ratio1.461NaN
Adjusted equity ratio-0.540NaN

CASH FLOW

Net income, $m-22NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-18NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m0NaN
Free cash flow, $m-18NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m7
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount